Video

Overview of the HER2+ Metastatic Breast Cancer Treatment Armamentarium

A key opinion leader in breast cancer management shares insight on the treatment armamentarium for patients with HER2+ disease.

Related Videos
Peter Schmid, MD, PhD, FRCP, discusses updated KEYNOTE-522 data showing that pembrolizumab plus chemotherapy improves EFS in early-stage TNBC.
1 expert in this video
1 expert in this video
David Rimm, MD, PhD
Vered Stearns, MD
1 expert in this video
1 expert in this video
Ruth M. O’Regan, MD